Oxidative Stress and Annexin A2 Differential Expression in Free Fatty Acids-Induced Non-Alcoholic Fatty Liver Disease in HepG2 Cells.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
04 Sep 2024
Historique:
received: 03 07 2024
revised: 22 08 2024
accepted: 26 08 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: epublish

Résumé

Non-alcoholic fatty liver disease (NAFLD) is a rising global burden, affecting one in four adults. Despite the increasing prevalence of NAFLD, the exact cellular and molecular mechanisms remain unclear, and effective therapeutic strategies are still limited. In vitro models of NAFLD are critical to understanding the pathogenesis and searching for effective therapies; thus, we evaluated the effects of free fatty acids (FFAs) on NAFLD hallmarks and their association with the modulation of Annexin A2 (ANXA2) and Keratin 17 (KRT17) in HepG2 cells. Our results show that oleic and palmitic acids can differentially induce intracellular lipid accumulation, cell death, and promote oxidative stress by increasing lipid peroxidation, protein carbonylation, and antioxidant defense depletion. Moreover, a markedly increased expression of inflammatory cytokines demonstrated the activation of inflammation pathways associated with lipotoxicity and oxidative stress. ANXA2 overexpression and KRT17 nuclear translocation were also observed, supporting the role of both molecules in the progression of liver disease. Taken together, these data provide insights into the interplay between ANXA2 and KRT17 in NAFLD, paving the way for understanding molecular mechanisms involved with the disease and developing new therapeutic strategies.

Identifiants

pubmed: 39273539
pii: ijms25179591
doi: 10.3390/ijms25179591
pii:
doi:

Substances chimiques

Annexin A2 0
Fatty Acids, Nonesterified 0
ANXA2 protein, human 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Fundação de Amparo à Pesquisa do Estado de Minas Gerais
ID : APQ-01564-18
Organisme : Fundação de Amparo à Pesquisa do Estado de Minas Gerais
ID : APQ-00760-18
Organisme : National Council for Scientific and Technological Development
ID : #403193/2022-2

Auteurs

Vinícius Marques Arruda (VM)

Laboratory of Metabolic Biochemistry and Redox Processes, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.
Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.

Gabriela Tolentino Azevedo (GT)

Laboratory of Metabolic Biochemistry and Redox Processes, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.
Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.

Maria Júlia Maia Gonçalves Granato (MJMG)

Laboratory of Metabolic Biochemistry and Redox Processes, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.

André Carlos Pereira Matos (ACP)

Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.

Thaise Gonçalves Araújo (TG)

Laboratory of Genetics and Biotechnology, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.

Joyce Ferreira da Costa Guerra (JFDC)

Laboratory of Metabolic Biochemistry and Redox Processes, Institute of Biotechnology, Federal University of Uberlandia, Patos de Minas 38700-002, Brazil.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH